← Leaderboards
Steven Francis Powell
Sanford Research/Usd
$1,463,949
Attributed
$1,463,949
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $297.8K · FY2016–20$500K$375K$250K$125K$0
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$1,463,949 · 1
By mechanism
P20$1,463,949 · 1
Top collaborators
No co-investigators on record.
Most similar at Sanford Research/Usd
Same institution · by research overlap
- William Charles Spanos$4,935,118
Others in their field
Top investigators on “Dose”
- Lawrence Corey · Fred Hutchinson Cancer Center$251,944,397
- Sharon A Nachman · Johns Hopkins University$213,337,729
- David Heimbrook · Leidos Biomedical Research, Inc.$146,807,554
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$134,297,561
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$124,321,134
- Peter C Adamson · National Childhood Cancer Foundation$122,197,823
Research focus
DoseExhaustCytokineCytotoxicityBaseDensityAntigensControl GroupsAmerican Society Of Clinical OncologyCd3 AntigensCd4 Positive T LymphocytesCd8b1 GeneBiological MarkersCell PhysiologyCellsBlood SpecimenCharacteristicsCancer BiologyChemoradiationChemotherapyCisplatinClinical DataClinical TrialsExhaustion
Grant awards (5)
The Impact of PD-1 Inhibition on Immune-Response to Chemoradiotherapy$288,946
P20 · FY2020 · GM · contact PI
The Impact of PD-1 Inhibition on Immune-Response to Chemoradiotherapy$289,592
P20 · FY2019 · GM · contact PI
The Impact of PD-1 Inhibition on Immune-Response to Chemoradiotherapy$289,754
P20 · FY2018 · GM · contact PI
The Impact of PD-1 Inhibition on Immune-Response to Chemoradiotherapy$297,828
P20 · FY2017 · GM · contact PI
The Impact of PD-1 Inhibition on Immune-Response to Chemoradiotherapy$297,829
P20 · FY2016 · GM · contact PI